Lv529
1120 积分 2023-10-28 加入
Perioperative chemotherapy and long-term cure in resected grade 3 gastroenteropancreatic neuroendocrine carcinomas: The GETNE SOUTH-NEC Study
18天前
已完结
Management of Localized Small and Large Cell Pancreatic Neuroendocrine Carcinoma in the National Cancer Database
19天前
已完结
Tumor microenvironment heterogeneity and progression mechanisms in intrahepatic cholangiocarcinoma: A study based on single-cell and spatial transcriptomic sequencing
24天前
已完结
Knockdown of circBFAR inhibits proliferation and glycolysis in gastric cancer by sponging miR-513a-3p/hexokinase 2 axis
27天前
已完结
Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases: a retrospective cohort study
27天前
已完结
Epigenetics and disease progression in neuroendocrine neoplasms
28天前
已完结
[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial
1个月前
已完结
First-In-Human [177Lu]Lu-FAPI-XT Therapy Combined With Anti-PD-1 Antibody in a Patient With Metastatic Colon Cancer Who Has Progressed on Multiple Prior Lines of Therapy
3个月前
已关闭
Patterns of Progression After Peptide Receptor Radiopharmaceutical Therapy
4个月前
已关闭
Therapeutic Efficacy of Neoadjuvant Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
4个月前
已关闭
皖公网安备34019202002308
